Announced Fri, 29 May · 22:12 IST

Please find enclosed financial results for the quarter and financial year ended March 31, 2026

Revenue DeclinePat NegativeExceptional ItemResults View source PDF

GENESYS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+2.5%1-day move
₹261.50
prior close
₹260.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.4-0.5+1.5+1.2+2.5+2.3+7.3+4.7+1.0+26.8+36.6+23.2
Up moveDown movePending
AI summary

Genesys International reported FY2026 consolidated revenue of ₹32,780.89 lakhs, up 5.4% from ₹31,103.15 lakhs in FY2025, showing modest revenue growth. However, standalone PAT declined sharply to ₹2,652.81 lakhs from ₹6,303.32 lakhs (down 57.9%) primarily due to an exceptional charge of ₹509.62 lakhs for reassessment of employee benefits under new labour codes. Consolidated PAT attributable to equity holders was ₹1,236.27 lakhs vs ₹1,894.70 lakhs. The company raised ₹11,000 lakhs via QIP in May 2025. Auditors MSKA & Associates LLP gave an unmodified opinion.

Likely market impact

The sharp standalone PAT decline despite revenue stability signals margin compression from higher employee costs and one-time exceptional charges. However, the QIP fundraise and consolidated revenue growth provide some cushion.